Revenue
$4.82B
Gross Margin
+61.8%
Operating Margin
+21.4%
Net Margin
+19.3%
Income statement waterfall for DexCom (DXCM) — TTM through Q1 2026
Net income: $930M
Margin breakdown for DexCom (DXCM) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $4.82B | $4.82B |
| Cost of Revenue | -$1.84B | $2.98B |
| Gross Profit | $2.98B | $2.98B |
| Operating Expenses | -$1.95B | $1.03B |
| Operating Income | $1.03B | $1.03B |
| Other Income / Expense | $170M | $1.2B |
| Pre-tax Income | $1.2B | $1.2B |
| Income Tax | -$273M | $930M |
| Net Income | $930M | $930M |
- Revenue$4.82B
- Cost of Revenue-$1.84B
- Gross Profit$2.98B
- Operating Expenses-$1.95B
- Operating Income$1.03B
- Other Income / Expense$170M
- Pre-tax Income$1.2B
- Income Tax-$273M
- Net Income$930M
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.